A Cancer Prodrug Activated by an Oncolytic Virus (#133)
Polly Chuanrong Sun
1
,
Laura Burga
2
,
Iman Kavianinia
1
,
Margaret Brimble
1
,
Mihnea Bostina
2
,
Alan Cameron
1
- School of Chemical Sciences, University of Auckland, Auckland, New Zealand
- Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand
Publish consent withheld
- McCarthy, C.; Jayawardena, N.; Burga, L. N.; Bostina, M. Developing picornaviruses for cancer therapy. Cancers 2019, 11 (5), 685.
- Jayawardena, N.; Burga, L. N.; Easingwood, R. A.; Takizawa, Y.; Wolf, M.; Bostina, M. Structural basis for anthrax toxin receptor 1 recognition by Seneca Valley Virus. Proceedings of the National Academy of Sciences 2018, 115 (46), E10934-E10940.